# An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis

> **NCT01782937** · PHASE3 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 30 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** KHK4827

## Key facts

- **NCT ID:** NCT01782937
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2015-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01782937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01782937, "An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01782937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*